The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors

The enthusiasm for immune checkpoint inhibitors (ICIs), an efficient tumor treatment model different from traditional treatment, is based on their unprecedented antitumor effect, but the occurrence of immune-related adverse events (irAEs) is an obstacle to the prospect of ICI treatment. IrAEs are a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Exp Clin Cancer Res
Hlavní autoři: Jia, Xiao-Hui, Geng, Lu-Ying, Jiang, Pan-Pan, Xu, Hong, Nan, Ke-Jun, Yao, Yu, Jiang, Li-Li, Sun, Hong, Qin, Tian-Jie, Guo, Hui
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7734811/
https://ncbi.nlm.nih.gov/pubmed/33317597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-020-01749-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky